Stay updated on Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial
Sign up to get notified when there's something new on the Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial page.

Latest updates to the Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision label updated from v3.5.2 to v3.5.3, indicating a small update to the page’s revision history. The update does not affect the main study details or visible content.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check29 days agoChange Detected- Updated site revision from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check36 days agoChange DetectedPadua, Italy was replaced by Padova, Italy in the locations list. This updates the site entry to the native Italian name for accuracy.SummaryDifference0.1%

- Check57 days agoChange DetectedAdded revision label v3.5.0 and removed revision label v3.4.3 from the page.SummaryDifference0.0%

- Check64 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check93 days agoChange DetectedRevision: v3.4.2 is now displayed, and the previous maintenance notice (Revision: v3.4.1) was removed.SummaryDifference0.4%

Stay in the know with updates to Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial page.